Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
The rise of infections caused by Mgen, C. auris, treatment-resistant E. coli, and more could become future public-health threats, experts say.
Last month Neil Sprackling, a CEO with Swiss Re, cited long COVID as a significant factor contributing to that two per cent ...
For those working in global health, and especially on immunisation, it is difficult not to feel despair at the headwinds in ...
Analysis of WHO's pandemic response highlights inconsistencies in new guidelines, raising concerns about the evidence base ...
Experiments suggests H9N2 has adapted to human cells, but cases of person-to-person transmission haven’t been reported yet ...
Seth Berkley, former CEO of Gavi, the Vaccine Alliance and co-founder of COVAX, discusses his new book “Fair Doses” and the ...
Epidemiologist Dr. Seth Berkley spoke to Live Science about the importance of vaccine equity and the obstacles undermining it, as well as the political challenges to vaccines being raised in the U.S.
The COVID-19 pandemic has provided researchers with a wealth of information on contemporary successes and failures in ...
Monday marks a full year of continuous measles transmission in Canada, a milestone that’s poised to set the country back ...
TORONTO — Canada is poised to lose its international status as a measles-free country now that an outbreak that began in New ...
Dr Michael Makanga, the Executive Director, Global Health European & Developing Countries Clinical Trials Partnership 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results